# Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

> **NCT07115953** · NA · RECRUITING · sponsor: **Medtronic Vascular** · enrollment: 130 (estimated)

## Conditions studied

- Hypertension
- Vascular Diseases
- Cardiovascular Diseases
- Chronic Kidney Diseases
- Diabetes Mellitus

## Interventions

- **DEVICE:** Symplicity Spyral™ multi-electrode renal denervation system

## Key facts

- **NCT ID:** NCT07115953
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2027-06-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07115953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07115953, "Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07115953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*